Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-1)

1. oktober 2026 oppdatert av: GlaxoSmithKline

En randomisert, dobbeltblind, placebokontrollert, parallellgruppe, multisenterstudie av effektiviteten og sikkerheten til depemokimab hos voksne deltakere med KOLS med type 2 betennelse

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.

Studieoversikt

Status

Rekruttering

Studietype

Intervensjonell

Registrering (Antatt)

981

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

      • Buenos Aires, Argentina, 1023
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Abel Esteban Bordon
      • Buenos Aires, Argentina, C1425AGC
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Manuela Garro
      • Buenos Aires, Argentina, C1425BEN
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Anahi Yanez
        • Ta kontakt med:
        • Ta kontakt med:
      • Buenos Aires, Argentina, C1121ABE
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Verónica Lawriwskyj
      • Buenos Aires, Argentina, 7600
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carlos De la Vega
      • Ciudad Autonoma de Bueno, Argentina, C1414AIF
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hernan Piza
      • Mendoza, Argentina, 5500
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Pablo Saez Scherbovsky
        • Ta kontakt med:
        • Ta kontakt med:
      • Mendoza, Argentina, M5500CCG
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pedro Carlos Elias
      • Paraná, Argentina, 3100
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Luis Larrateguy
      • Rosario, Argentina, S2002OJN
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Fernando Massola
      • San Juan Bautista, Argentina, 1888
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrea Medina
      • San Miguel de Tucumán, Argentina, T4000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hector Altieri
      • San Miguel de Tucumán, Argentina, T4000IFL
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Roxana Willigs Rolon
      • San Miguel de Tucumán, Argentina, 4000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mercedes Espeche
    • Provincia de Bs AS
      • La Plata, Provincia de Bs AS, Argentina, 1900
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • GABRIEL GARCIA
      • Aalst, Belgia, 9300
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dimitri Stylemans
      • Genk, Belgia, 3600
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • David Ruttens
      • Kortrijk, Belgia, 8500
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mathias Leys
      • Liège, Belgia, 4000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Florence Schleich
        • Hovedetterforsker:
          • Geoffroy de Fooz
      • Namur, Belgia, 5101
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jean-Benoît MARTINOT
      • Sint-Niklaas, Belgia, 9100
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jonas Yserbyt
    • British Columbia
      • Richmond, British Columbia, Canada, V6V 2L1
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alexandra Lucas
    • Ontario
      • Ajax, Ontario, Canada, L1S 2J5
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • George Philteos
        • Ta kontakt med:
        • Ta kontakt med:
      • Toronto, Ontario, Canada, M5T 3A9
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Kenneth Chapman
        • Ta kontakt med:
        • Ta kontakt med:
      • Windsor, Ontario, Canada, N8X 1T3
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Syed Anees
        • Ta kontakt med:
        • Ta kontakt med:
    • Quebec
      • Saint-Charles-Borromée, Quebec, Canada, J6E 2B4
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Bonavuth Pek
        • Ta kontakt med:
        • Ta kontakt med:
      • Sherbrooke, Quebec, Canada, J1L 0H8
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Philippe Lachapelle
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada, S7N 0W8
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Darcy Marciniuk
      • Curicó, Chile, 3341643
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Victor Martinez Hagen
      • Aalborg, Danmark, 9000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ulla Moller Weinreich
      • Hvidovre, Danmark, 2650
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Charlotte Ulrik
    • Region Sjælland
      • Roskilde, Region Sjælland, Danmark, 4000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Christian Meyer
    • California
      • Bakersfield, California, Forente stater, 93301
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Tonny Tanus
        • Ta kontakt med:
        • Ta kontakt med:
      • Modesto, California, Forente stater, 95355-4046
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jose Rodriguez
      • Newport Beach, California, Forente stater, 92663
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ryan Klein
    • Delaware
      • Wilmington, Delaware, Forente stater, 19803
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carole Guy
    • Florida
      • Bradenton, Florida, Forente stater, 34209
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Patrick Weston
      • Brandon, Florida, Forente stater, 33511-5706
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rafael Martinez
        • Ta kontakt med:
      • Hialeah, Florida, Forente stater, 33012
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Alberto Manzor
        • Ta kontakt med:
        • Ta kontakt med:
      • Hialeah, Florida, Forente stater, 33016
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Juan Fernandez
      • Loxahatchee Groves, Florida, Forente stater, 33470
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Neal Warshoff
        • Ta kontakt med:
        • Ta kontakt med:
      • Miami, Florida, Forente stater, 33126
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Anish Dhadwal
        • Ta kontakt med:
        • Ta kontakt med:
      • Miami, Florida, Forente stater, 33155
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Guillermo Somodevilla
        • Ta kontakt med:
        • Ta kontakt med:
      • Miami Lakes, Florida, Forente stater, 33016
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maria Elena Ocasio
      • Orange City, Florida, Forente stater, 32763
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kristyna Paradis
      • Palm Springs, Florida, Forente stater, 33406
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Luis Castillo Hernandez
        • Ta kontakt med:
        • Ta kontakt med:
      • Palmetto Bay, Florida, Forente stater, 33176-7296
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael Feldman
      • Pensacola, Florida, Forente stater, 32503-2698
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Bercz
      • Tamarac, Florida, Forente stater, 33321
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Neena Chandrasekaran
      • Tampa, Florida, Forente stater, 33614
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • GERMAN ALVAREZ
      • The Villages, Florida, Forente stater, 32162
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Angela Okolie
    • Georgia
      • Riverdale, Georgia, Forente stater, 30274
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Deon Miller
        • Ta kontakt med:
        • Ta kontakt med:
      • Stonecrest, Georgia, Forente stater, 30038
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rabahuddin Syed
    • Illinois
      • Chicago, Illinois, Forente stater, 60611
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Daniel Meza
    • Maryland
      • Baltimore, Maryland, Forente stater, 21224
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sarath Raju
    • Michigan
      • Clarkston, Michigan, Forente stater, 48346
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dean Moscovic
      • Flint, Michigan, Forente stater, 48504-4730
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ahmed Arif
    • Missouri
      • St Louis, Missouri, Forente stater, 63110
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kaharu Sumino
    • Nevada
      • Henderson, Nevada, Forente stater, 89052-5015
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vikas Sayal
      • Las Vegas, Nevada, Forente stater, 89123-2874
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Vrijendra Hoon
        • Ta kontakt med:
        • Ta kontakt med:
      • Reno, Nevada, Forente stater, 89502
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Farah Madhani-Lovely
    • New York
      • North Massapequa, New York, Forente stater, 11758
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael DiGiovanna
    • North Carolina
      • Winston-Salem, North Carolina, Forente stater, 27103
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Farhan Ahmed
      • Winston-Salem, North Carolina, Forente stater, 27104
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jessica Bon
    • South Carolina
      • Greenville, South Carolina, Forente stater, 29607
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Eric Garcia-Torres
      • Rock Hill, South Carolina, Forente stater, 29732
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Michael Denenberg
        • Ta kontakt med:
        • Ta kontakt med:
    • Tennessee
      • Franklin, Tennessee, Forente stater, 37067
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Aaron Milstone
        • Ta kontakt med:
        • Ta kontakt med:
    • Texas
      • Corsicana, Texas, Forente stater, 75110
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • John Updegrove
      • Dallas, Texas, Forente stater, 75234
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Chaitanya Tatineni
      • Houston, Texas, Forente stater, 77084
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ajay Jain
      • Houston, Texas, Forente stater, 77089
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sandeep Gupta
      • Houston, Texas, Forente stater, 77058-2805
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alfred Maksoud
      • McKinney, Texas, Forente stater, 75069
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Shahrukh Kureishy
      • Pearland, Texas, Forente stater, 77584
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mohammad Siddiqui
      • Amiens, Frankrike, 80054
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Claire ANDREJAK
        • Ta kontakt med:
        • Ta kontakt med:
      • Blois, Frankrike, 41000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alexandre Bleinc
      • Caen, Frankrike, 14000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aurelien Justet
      • La Tronche, Frankrike, 38700
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bruno Degano
      • Lyon, Frankrike, 69004
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gilles Devouassoux
      • Nice, Frankrike, 06001
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Valentin Stalder
      • Pessac, Frankrike, 33600
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pierre-Olivier GIRODET
      • Toulouse, Frankrike, 31059
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sandrine Pontier-Marchandise
      • Villeurbanne, Frankrike, 69100
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jean-Marc Dot
    • Aisne
      • Saint-Quentin, Aisne, Frankrike, 2100
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • DOUADI YOUCEF
    • Bouches-du-Rhône
      • Marseille, Bouches-du-Rhône, Frankrike, 13015
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marion Gouitaa
      • Cork, Irland, T12 DC4A
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Desmond Murphy
        • Ta kontakt med:
        • Ta kontakt med:
      • Drogheda, Irland, A92 VW28
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Omar Omaima
      • Dublin, Irland, D15 X40D
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Abirami Subramaniam
      • Galway, Irland
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael Harrison
      • Mullingar, Irland, N91 NA43
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Junaid Khan
    • Co. Dublin
      • Dublin, Co. Dublin, Irland, NR0A
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Patrick Mitchell
      • Chiba, Japan, 260-8677
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jun Ikari
      • Chiba, Japan, 279-0001
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yasuhiro Norisue
      • Chiba, Japan, 260-0852
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yasuo Takiguchi
      • Fukuoka, Japan, 805-8508
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kunihiro Suzuki
      • Fukuoka, Japan, 802-0052
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tetsuya Kawano
      • Fukuoka, Japan, 820-8505
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kazunori Tobino
      • Fukuoka, Japan, 812-0054
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Isamu Okamoto
        • Ta kontakt med:
        • Ta kontakt med:
      • Fukushima, Japan, 960-1295
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yoko Shibata
      • Gifu, Japan, 509-6134
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hiroyuki Ohbayashi
      • Hokkaido, Japan, 062-0931
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Satoshi Fuke
      • Hyōgo, Japan, 663-8501
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Takashi Kijima
      • Hyōgo, Japan, 672-8064
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yuji Nakatani
      • Hyōgo, Japan, 650-0047
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ryo Tachikawa
      • Hyōgo, Japan, 651-0053
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hiroki Kawabata
      • Hyōgo, Japan, 670-0849
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kunihiko Terada
      • Ibaraki, Japan, 300-0812
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Norihiro Kikuchi
      • Ishikawa, Japan, 920-8650
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toshiyuki Kita
      • Kagawa, Japan, 762-0043
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hiroyuki Nakamura
      • Kanagawa, Japan, 232-0024
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • makoto kudo
      • Kanagawa, Japan, 221-0855
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kazuhito Miyazaki
      • Kanagawa, Japan, 229-1103
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jun Shinada
      • Kyoto, Japan, 610-0113
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kensuke Sumi
      • Mie, Japan, 515-8544
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Osamu Hataji
      • Mie, Japan, 510-8561
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Masamichi Yoshida
        • Ta kontakt med:
        • Ta kontakt med:
      • Nankoku-shi, Japan, 783-8509
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tsutomu Shinohara
      • Niigata, Japan, 940-0840
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toshio Kiguchi
      • Niigata, Japan, 940-8621
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hideo Sato
      • Okayama, Japan, 701-1192
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Keiichi Fujiwara
      • Omuta Shi, Japan, 837-0911
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Satoru Fukuyama
      • Osaka, Japan, 543-8555
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Chie Yoshimura
      • Osaka, Japan, 560-8552
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Keisuke Miki
        • Ta kontakt med:
        • Ta kontakt med:
      • Osaka, Japan, 586-8521
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Miyuki Okuda
      • Shizuoka, Japan, 430-8525
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Mikio Toyoshima
        • Ta kontakt med:
        • Ta kontakt med:
      • Shizuoka, Japan, 420-0853
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Masato Fujii
      • Shizuoka, Japan, 432-8002
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jun Sato
      • Shizuoka, Japan, 426-0077
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Naoki Koshimizu
        • Ta kontakt med:
        • Ta kontakt med:
      • Shizuoka, Japan, 434-0015
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yutaro Nakamura
      • Tokyo, Japan, 103-0027
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Arihiro Kiyosue
      • Tokyo, Japan, 162-8655
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Manabu Suzuki
      • Tokyo, Japan, 113-8431
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kengo Koike
      • Tokyo, Japan, 105-8471
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Takanori Numata
      • Tokyo, Japan, 104-0031
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yasushi Fukushima
      • Tokyo, Japan, 140-8522
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Masaharu Shinkai
      • Tokyo, Japan, 204-8522
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hiroyuki Kokuto
      • Yamaguchi, Japan, 755-0067
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tsunahiko Hirano
      • Yokohama, Japan, 236-0004
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Yu Hara
        • Ta kontakt med:
        • Ta kontakt med:
    • Fukuoka
      • Kitakyushu-shi, Fukuoka, Japan, 807-8555
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kazuhiro Yatera
      • Beijing, Kina, 100020
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Yingxiang lin
        • Ta kontakt med:
        • Ta kontakt med:
      • Beijing, Kina, 100034
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • guangfa wang
        • Ta kontakt med:
        • Ta kontakt med:
      • Changchun, Kina, 130021
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Liping Peng
        • Ta kontakt med:
        • Ta kontakt med:
      • Changchun, Kina, 130041
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • wang ke
      • Changsha, Kina, 410013
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lihua Xie
      • Chengdu, Kina, 610041
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • fuqiang Wen
      • Chongqing, Kina, 400038.
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Xiangdong Zhou
        • Ta kontakt med:
        • Ta kontakt med:
      • Dongguan, Kina, 523059
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Guodong Hu
      • Fuyang, Kina, 236000
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Bin Liu
        • Ta kontakt med:
        • Ta kontakt med:
      • Guangzhou, Kina, 510150
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Hovedetterforsker:
          • Liping Wei
        • Ta kontakt med:
      • Guangzhou, Kina, 510180
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhuxiang Zhao
      • Guilin, Kina, 541002
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bin Huang
      • Hangzhou, Kina, 310005
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Sheng Huang
        • Ta kontakt med:
        • Ta kontakt med:
      • Hangzhou, Kina, 310000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Limin Wang
      • Hefei, Kina, 230001
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiaodong Mei
      • Hohhot, Kina, 010017
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maoye Xu
      • Hohhot, Kina, 010050
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Xiuhua Fu
        • Ta kontakt med:
        • Ta kontakt med:
      • Huizhou, Kina, 516000
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Feng Wu
        • Ta kontakt med:
        • Ta kontakt med:
      • Huizhou, Kina, 516001
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • changqing lin
      • Jiangmen, Kina, 529000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mingjiang Lin
      • Jiangmen, Kina, 529030
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • yanming huang
        • Ta kontakt med:
        • Ta kontakt med:
      • Jiangsu, Kina, 221004
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Bi Chen
        • Ta kontakt med:
        • Ta kontakt med:
      • Jiangxi, Kina
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Limin Dong
      • Jinan, Kina, 250012
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Yiqing Qu
        • Ta kontakt med:
        • Ta kontakt med:
      • Kunming, Kina
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yunhui Zhang
      • Kunming, Kina, 650032
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhuang Luo
      • Lianyungang, Kina, 222006
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Fukuan Zhong
      • Liuzhou, Kina, 545006
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Lin Chen
        • Ta kontakt med:
        • Ta kontakt med:
      • Meizhou, Kina, 514700
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • du yanjia
      • Mianyang, Kina
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Weiguo Xu
        • Ta kontakt med:
        • Ta kontakt med:
      • Nanchang, Kina, 330038
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiya Wu
      • Nanchang, Kina, 330000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Qing Yang
      • Qingdao, Kina, 266011
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • wei han
      • Qingyuan, Kina, 511500
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dongbo Tian
      • Qinhuangdao, Kina, 66000
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Hua Qiao
        • Ta kontakt med:
        • Ta kontakt med:
      • Shanghai, Kina, 200032
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Yuanlin Song
        • Ta kontakt med:
        • Ta kontakt med:
      • Shanghai, Kina
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xianghuai XU
      • Shanghai, Kina, 201199
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiwen Gao
      • Shanghai, Kina, 201299
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wenchao Gu
      • Suzhou, Kina
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wei Lei
      • Taiyuan, Kina, 300201
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yi Jiang
      • Taizhou, Kina, 317000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jiaxi Feng
      • Weifang, Kina
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Guoru Yang
      • Wenzhou, Kina, 325000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Liqin wu
      • Wuhan, Kina, 430014
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Yi Hu
        • Ta kontakt med:
        • Ta kontakt med:
      • Wuxi, Kina, 214023
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Tao Bian
        • Ta kontakt med:
        • Ta kontakt med:
      • Xi'an, Kina, 710061
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Manxiang Li
      • Xiamen, Kina, 361004
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Huiqing Zeng
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yihua Lin
      • Yinchuan, Kina, 750001
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Lijun Chen
        • Ta kontakt med:
        • Ta kontakt med:
      • Zhanjiang, Kina, 524045
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Junxian Chen
      • Zhengzhou, Kina, 450052
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aiguo Xu
      • Zigong, Kina, 643036
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhiping Deng
      • Ürümqi, Kina, 830054
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • wang zaiyi
    • Hainan
      • Haikou, Hainan, Kina, 570311
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wu Haihong
    • Hunan
      • Changsha, Hunan, Kina, 410015
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yingqun Zhu
    • Sichuan
      • Chengdu, Sichuan, Kina, 611130
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiao Liu
      • Split, Kroatia, 21000
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Vide Popovic
        • Ta kontakt med:
        • Ta kontakt med:
      • Zagreb, Kroatia, 10000
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mirna Vergles
      • Deventer, Nederland, 7416 SE
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Margriet Stellingwerf
      • Enschede, Nederland, 7512 KZ
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wendy J.C. Moeskops-van Beurden
      • Harderwijk, Nederland, 3844 DG
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lisenka N. Boom
      • Hoofddorp, Nederland, 2134 TM
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marijke Amelink
      • Nijmegen, Nederland, 6532 SZ
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rob Janssen
    • Gelderland
      • Zutphen, Gelderland, Nederland, 7207 AE
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Martijn Goosens
        • Ta kontakt med:
        • Ta kontakt med:
    • North Brabant
      • Breda, North Brabant, Nederland, 4818 CK
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Simone van der Sar
        • Ta kontakt med:
        • Ta kontakt med:
    • Overijssel
      • Zwolle, Overijssel, Nederland, 8025 AB
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jan Willem K. van den Berg
    • Akershus
      • Lørenskog, Akershus, Norge, 1474
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Gunnar Einvik
        • Ta kontakt med:
        • Ta kontakt med:
      • Bialystok, Polen, 15-044
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Robert Mroz
      • Bydgoszcz, Polen, 85-796
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jacek Dulęba
      • Krakow, Polen, 30-033
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Grażyna Pulka
      • Poznan, Polen, 60-693
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michał Springer
      • Rzeszów, Polen, 35-051
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Małgorzata Pawlukiewicz
      • Rzeszów, Polen, 35-205
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Slawomir Tokarski
      • Wroclaw, Polen, 54-153
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ewa Pisarczyk-Bogacka
    • Greater Poland Voivodeship
      • Poznan, Greater Poland Voivodeship, Polen, 61-578
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Danuta Madra-Rogacka
    • Silesian Voivodeship
      • Katowice, Silesian Voivodeship, Polen, 40-954
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Krzysztof Filipek
      • Guarda, Portugal, 6300-749
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • José Silva
      • Lisbon, Portugal, 1649-035
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paula Pinto
      • Lisbon, Portugal, 1500-458
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Susana Moreira
      • Lisbon, Portugal, 1500-650
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mónica Grafino
      • Setúbal, Portugal, 2900-722
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marta Fradinho
      • Vila Nova de Gaia, Portugal, 4400-346
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nuno Cortesao
    • Lisbon District
      • Loures, Lisbon District, Portugal, 2674-514
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Teresa Martin
    • Porto District
      • Senhora da Hora, Porto District, Portugal, 4464-513
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Daniel Reis
    • Setúbal District
      • Almada, Setúbal District, Portugal, 2805-267
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carlos Couto
      • Košice, Slovakia, 040 01
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Martin Orolin
      • Spišská Nová Ves, Slovakia, 052 01
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Slavomir Hrebenar
      • Alzira, Spania, 46600
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Elsa Naval Sendra
        • Ta kontakt med:
        • Ta kontakt med:
      • Barcelona, Spania, 8035
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Miriam Barrecheguren Fernández
        • Ta kontakt med:
        • Ta kontakt med:
      • Benalmádena, Spania, 29639
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gustavo De Luiz Martinez
      • Ferrol, Spania, 15405
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carlota Rodríguez
      • GaldakaoVizcaya, Spania, 48960
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amaia Aramburu Ojembarrena
      • Madrid, Spania, 28040
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carolina María Gotera Rivera
      • Madrid, Spania, 28050
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Walther Ivan Giron Matute
      • Marbella, Spania, 29603
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • María del Carmen Morillo Domínguez
      • Málaga, Spania, 29010
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Esperanza Doña Díaz
        • Hovedetterforsker:
          • José Luis Velasco Garrido
      • Palma de Mallorca, Spania, 070120
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Francisco de Borja García-Cosio Piqueras
      • Santander, Spania, 39008
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carlos Amado Diago
      • Seville, Spania, 41009
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Agustín Salvador Valido Morales
      • Zaragoza, Spania, 50009
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marta Marin Oto
    • Madrid
      • Pozuelo de Alarcón, Madrid, Spania, 28223
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jose Maria Echave-Sustaeta
    • Málaga
      • Marbella, Málaga, Spania, 29603
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jose Maria Ignacio
      • Aarau, Sveits, 5001
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hans-Joachim Kabitz
      • Zurich, Sveits, 8636
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marc Spielmanns
      • Lund, Sverige, SE-222 22
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Anders Luts
      • Stockholm, Sverige, 11727
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • AKE OLSSON
      • Stockholm, Sverige, SE-113 29
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Bosson
      • Changhua, Taiwan, 50006
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ching-Hsiung Lin
      • Kaohsiung City, Taiwan, 80756
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Chau-Chyun Sheu
      • Taichung, Taiwan, 407219
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ming-Cheng Chan
      • Taichung, Taiwan, 433
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ming-Lin Ho
      • Taipei, Taiwan, 11031
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pai-Chien Chou
      • Taipei, Taiwan, 11490
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Chen-Liang Tsai
      • Taipei, Taiwan, 220
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Shih-Lung Cheng
        • Ta kontakt med:
        • Ta kontakt med:
      • Çanakkale, Tyrkia (Türkiye), 17020
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pinar Mutlu
      • İzmit, Tyrkia (Türkiye), 41380
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • İlknur Başyiğit
    • Balcova
      • Izmir, Balcova, Tyrkia (Türkiye), 35340
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aylin Alpaydin
    • Konyaaltı
      • Antalya, Konyaaltı, Tyrkia (Türkiye), 7070
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aykut Cilli
    • Pamukkale
      • Denizli, Pamukkale, Tyrkia (Türkiye), 20070
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nese Dursunoglu
      • Ahrensburg, Tyskland, 22926
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sameer Kulkarni
      • Berlin, Tyskland, 12157
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Michael Sebert
        • Ta kontakt med:
        • Ta kontakt med:
      • Berlin, Tyskland, 14059
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Timo Weiss
      • Bonn, Tyskland, 53127
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Dirk Skowasch
        • Ta kontakt med:
        • Ta kontakt med:
      • Frankfurt am Main, Tyskland, 60389
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Claus Keller
        • Ta kontakt med:
        • Ta kontakt med:
      • Frankfurt am Main, Tyskland, 60596
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Marc Oliver Kornmann
        • Ta kontakt med:
        • Ta kontakt med:
      • Giessen, Tyskland
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Natascha Sommer
      • Kiel, Tyskland, 24105
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jan Heyckendorf
      • Mainz, Tyskland, 55128
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Stephanie Korn
        • Ta kontakt med:
        • Ta kontakt med:
      • München, Tyskland, 81241
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Rainald Fischer
        • Ta kontakt med:
        • Ta kontakt med:
      • Wiesbaden, Tyskland, 65183
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Fried
      • Wuppertal, Tyskland, 42283
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sven Stieglitz
      • Würzburg, Tyskland, 97074
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Stefan Baron
    • Baden-Wurttemberg
      • Löwenstein, Baden-Wurttemberg, Tyskland, 74245
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Biljana Joves
    • Bavaria
      • Donaustauf, Bavaria, Tyskland, 93093
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Maximilian Malfertheiner
    • Lower Saxony
      • Peine, Lower Saxony, Tyskland, 31224
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Christian Schlenska
        • Ta kontakt med:
        • Ta kontakt med:
    • North Rhine-Westphalia
      • Essen, North Rhine-Westphalia, Tyskland, 45239
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sivagurunathan Sutharsan
      • Budapest, Ungarn, 1044
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alpar HORVATH
      • Budapest, Ungarn, 1121
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ildikó Horváth
      • Pécs, Ungarn, 7635
        • Rekruttering
        • GSK Investigational Site
        • Hovedetterforsker:
          • Marta Papp
        • Ta kontakt med:
        • Ta kontakt med:
      • Törökbálint, Ungarn, 2045
        • Rekruttering
        • GSK Investigational Site
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gabriella Gálffy

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 80 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Participants must be greater than or equal to (>=) 40 to less than or equal to (<=) 80 years of age, at the time of signing the informed consent

  • Elevated blood eosinophil count (BEC).

  • Moderate to severe COPD with frequent exacerbations, defined as:

    • A clinically documented history of COPD as defined by the American Thoracic Society/European Respiratory Society for at least 1 year
    • A post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio of less than (<) 0.70 and a post- bronchodilator FEV1 >30 percent (%) and <= 80% predicted normal values
    • A well-documented history of at least 2 moderate or 1 severe exacerbation in the 12 months prior to screening
  • COPD assessment test (CAT) score >=10 at Visit 1

  • Smoking status: Current or former cigarette smokers with a history of cigarette smoking of >=10 pack-years.

  • Participants should be on optimized inhaler therapy, defined as inhaled corticosteroid (ICS) plus Long-acting muscarinic receptor antagonist (LAMA) plus Long-acting beta2-adrenergic receptor agonist (LABA) either as multiple inhalers or a single combination inhaler for at least 6 months prior to Screening Visit 1

  • Body mass index (BMI) >=16 kilogram per square meter (kg/m^2).

  • Male or eligible female participants

Exclusion Criteria:

The following subjects are excluded:

  • Participants with a current or prior physician diagnosis of asthma
  • Other clinically significant lung disease: The Investigator must judge that COPD is the primary diagnosis accounting for the clinical manifestations of the lung disease
  • Participants with pneumonia, COPD exacerbation, or lower respiratory tract infection within the 4 weeks prior to Screening Visit 1
  • Lung resection: Participants with a history of, or plan for lung volume reduction surgery / endobronchial valve procedure
  • Pulmonary rehabilitation: Participants in the acute phase of a pulmonary rehabilitation program within 4 weeks prior to Screening Visit 1.
  • Continuous oxygen: Participants requiring oxygen supplementation for more than 16 hours per day to maintain resting oxygen saturation greater than 88%
  • Cor pulmonale - resulting in right heart failure, severe pulmonary hypertension
  • Chronic hypercapnia requiring Non-invasive positive pressure ventilation (NIPPV) use (including Bi-Level Positive Airway Pressure [BiPAP] or Continuous Positive Airway Pressure [CPAP])
  • Unstable cardiovascular disease or arrhythmia.
  • Parasitic Infection: Participants with a known, pre-existing parasitic infection within 6 months of Screening (Visit 1)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Depemokimab

Participants will be administered depemokimab along with standard of care (SoC).

Depemokimab as a sterile liquid formulation will be administered.

Andre navn:
  • GSK3511294
Placebo komparator: Placebo

Participants will be administered placebo along with SoC.

Placebo as a sterile 0.9 percent (%) sodium chloride solution will be administered.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Annualized Rate of Moderate/Severe Exacerbations
Tidsramme: From Baseline up to Week 104

Moderate exacerbations are defined as clinically significant exacerbations that require treatment with oral/systemic corticosteroids and/or antibiotics. Severe exacerbations are defined as clinically significant exacerbations that require in-patient hospitalization (i.e., greater than or equal to [>=] 24 hours) or result in death. The frequency of moderate/ severe exacerbations expressed as an annualized exacerbation rate will be evaluated.

From Baseline up to Week 104

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Time to First Moderate/Severe Exacerbation
Tidsramme: From Baseline up to Week 104

Moderate exacerbations are defined as clinically significant exacerbations that require treatment with oral/systemic corticosteroids and/or antibiotics. Severe exacerbations are defined as clinically significant exacerbations that require in-patient hospitalization (i.e., greater than or equal to [>=] 24 hours) or result in death.

From Baseline up to Week 104
Change From Baseline in St. Georges Respiratory Questionnaire (SGRQ) Total Score at Week 52
Tidsramme: From Baseline up to Week 52

The SGRQ total score will be measured using the SGRQ for COPD [SGRQ-C]. The SGRQ-C is a 40-item participant questionnaire designed to measure health impairment by addressing the frequency of respiratory symptoms (questions 1-7) and the participant's current state (questions 8-14). The questions are designed to be self-completed by the participant. The total score will be calculated on 0-100 rating scale and scores expressed as a percentage of overall impairment. Higher scores indicate greater impairment of health.

From Baseline up to Week 52
Change From Baseline in Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS: COPD) Total Score at Week 52
Tidsramme: From Baseline up to Week 52

E-RS: COPD consists of 11 items from the 14-item Exacerbations of Chronic Pulmonary Disease Tool - Patient Reported Outcomes (EXACT) instrument. E-RS: COPD is intended to capture information related to the respiratory symptoms of COPD, i.e., breathlessness, cough, sputum production, chest congestion, and chest tightness. The ERS: COPD has a scoring range of 0 to 40, higher scores indicate more severe symptoms.

From Baseline up to Week 52
Annualized Rate of Exacerbations Requiring Emergency Department (ED) Visit or Hospitalization
Tidsramme: From Baseline up to Week 104

Annualized rate of exacerbations requiring ED Visit or Hospitalization (For pooled analysis across studies 222714 and 222725) will be assessed.

From Baseline up to Week 104
Annualized Rate of Severe Exacerbations
Tidsramme: From Baseline up to Week 104

Severe exacerbations are defined as clinically significant exacerbations that require in-patient hospitalization (i.e., greater than or equal to [>=] 24 hours) or result in death. Annualized rate of severe exacerbations (For pooled analysis across studies 222714 and 222725) will be assessed.

From Baseline up to Week 104

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Studieleder: GSK Clinical Trials, GlaxoSmithKline

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

20. juni 2025

Primær fullføring (Antatt)

13. desember 2028

Studiet fullført (Antatt)

14. februar 2029

Datoer for studieregistrering

Først innsendt

28. april 2025

Først innsendt som oppfylte QC-kriteriene

28. april 2025

Først lagt ut (Faktiske)

6. mai 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. oktober 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Study Sponsor will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://www.gsk-studyregister.com/gsk-patient-level-data-sharing-july2025.pdf

IPD-delingstidsramme

Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or asset(s) with development terminated across all indications.

Tilgangskriterier for IPD-deling

Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension may be granted, when justified, for up to 6 months.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF
  • CSR

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere